Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Erjefält, Jonas
NCT05689931: Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma: Influence of Systemic IL-5 Targeting	Recruiting	N/A	80	Europe	Mepolizumab, Mepolizumab (brand name: Nucala), Standard inhaled corticosteroids (ICS) and long-acting beta 2 agonists (LABA), ICS and LABA	Region Skane, Lund University	Asthma	04/24	12/24
Aronsson, David
NCT05689931: Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma: Influence of Systemic IL-5 Targeting	Recruiting	N/A	80	Europe	Mepolizumab, Mepolizumab (brand name: Nucala), Standard inhaled corticosteroids (ICS) and long-acting beta 2 agonists (LABA), ICS and LABA	Region Skane, Lund University	Asthma	04/24	12/24